Agoracom: Small Cap Investment - Zenith Epigenetics - Another Promissory Note -Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Another Promissory Note -Exempt Distribution

posted on Jul 17, 2024 07:21AM

Promissory Note: Dated 2024-07-10 for $ 544,944.00

With 550K warrants @ $1.02 expire, 2029-07-10

Out of Alberta (Accredited Investor)

Koo

1 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply